22 Apr TPS Buy report
VIR- VIR Biotechnology $30 area Infectious diseases are among the leading causes of death worldwide. Vir is focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. 3.3 Billion market Cap CEO former CEO of Biogen Well cashed up with over...